B
Bull
Bull · 25%ZIMV
$6.37
Szenariopreis
$18.990
0.000 (0.00%)Zum Schluss
Loading chart…
- High
- 19.000
- Open
- 18.990
- VWAP
- 18.99
- Vol
- 653.57K
- Mkt Cap
- 480.01M
- Low
- 18.990
- Amount
- 12.41M
- EV/EBITDA, TTM
- 7.26
ZimVie Inc. is a global life sciences company in the dental market. It develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. It works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems, dental biomaterial products and digital dentistry solutions. The key products in its dental implant systems portfolio consist of TSX Implant System, Tapered Screw-Vent (TSV) Implant System, T3 Pro Implant System, T3 Implant System, OSSEOTITE Implant System, Trabecular Metal Implant System, BellaTek Patient Specific Products, GenTek Restorative Portfolio, and Encode Healing Abutment / Impression System. It markets its products in about 50 countries.
Bewertungskennzahlen
The current forward P/E ratio for ZimVie Inc (ZIMV) is 17.35, compared to its 5-year average forward P/E of 17.18.
Alphio AI Price Scenarios for ZIMV
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Whales holding ZIMV
Event-Zeitleiste
News
8.510-20NewsfilterZimVie Confirms Finalization of Acquisition by ARCHIMED
- 8.510-10Newsfilter
ZimVie Shareholders Approve ARCHIMED Acquisition
7.009-22PRnewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, ZIMV, SPNS on Behalf of Shareholders
7.009-16GlobenewswireSHAREHOLDER INQUIRY: Halper Sadeh LLC Probes ZIMV, ARIS, SCPH for Shareholder Interests
7.009-09PRnewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZIMV, MBC, CORZ, SOL on Behalf of Shareholders
ZIMV FAQ — answered by Alphio AI
ZimVie Inc. is a global life sciences company in the dental market. It develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. It works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems, dental biomaterial products and digital dentistry solutions. The key products in its dental implant systems portfolio consist of TSX Implant System, Tapered Screw-Vent (TSV) Implant System, T3 Pro Implant System, T3 Implant System, OSSEOTITE Implant System, Trabecular Metal Implant System, BellaTek Patient Specific Products, GenTek Restorative Portfolio, and Encode Healing Abutment / Impression System. It markets its products in about 50 countries. It operates in the Healthcare sector (DENTAL EQUIPMENT & SUPPLIES industry).
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.